Dr. Iturria-Medina[/caption]
Yasser Iturria-Medina PhD
Assistant Professor, Department of Neurology and Neurosurgery
Associate member of the Ludmer Centre for Neuroinformatics and
Mental Health McConnell Brain Imaging Centre
McGill University
MedicalResearch.com: What is the background for this study?
Response: As background, two main points:
Dr. Juraschek[/caption]
Stephen P. Juraschek, MD, PhD
Assistant Professor, Harvard Medical School
Beth Israel Deaconess Medical Center
Division of General Medicine, Section for Research
Boston, MA 02215
MedicalResearch.com: What is the background for this study?
Response: Gout is a common complication of blood pressure treatment. Furthermore, 75% of adults with gout have hypertension. There are several classes of medications uses to treat hypertension. While prior studies have reported that calcium channel blockers like amlodipine lower uric acid, its effects on gout risk compared to other common first-line antihypertensive agents are unknown.
David Stack[/caption]
Dave Stack
Chief Executive Officer and Chairman
Pacira BioSciences
MedicalResearch.com: What is the background for this study?
Response: Cesarean sections (C-sections) are one of the most common surgeries in the United States, and research shows many women experience moderate to severe pain after this procedure. When postsurgical pain is inadequately managed for new mothers, it can interfere with recovery, maternal-infant bonding and may even lead to postpartum depression. Additionally, prescribing data reveals that postsurgical opioid consumption poses a great risk to women.
We recently completed a Phase 4 study of EXPAREL in C-section patients, and results revealed adding EXPAREL to bupivacaine transversus abdominis plane (TAP) blocks for C-section delivery provided significant reductions in opioids and pain scores. Results of that study provided the basis for the design of this next-generation study, which was created to be completely opioid-free in the EXPAREL arm.
The study was a Phase 4 multicenter, active-controlled study conducted in 18 clinical sites in the United States, with 169 enrolled patients undergoing elective C-section. The enrolled C-section patients were randomized to receive either 150 mcg morphine spinal anesthesia plus a standard of care postoperative pain regimen, 50 mcg morphine spinal anesthesia plus EXPAREL TAP field block, or opioid-free spinal anesthesia plus EXPAREL TAP block. Patients in the EXPAREL arms received a protocol-defined non-opioid postsurgical pain management regimen including ketorolac, acetaminophen, and ibuprofen.
Prof. Woloshin[/caption]
Steven Woloshin, MD, MS
Professor of Medicine and Community and Family Medicine
Professor, The Dartmouth Institute for Health Policy and Clinical Practice
MedicalResearch.com: What is the background for this study?
Response: Industry spends more on detailing visits and free samples than any other form of prescription drug marketing. There is good evidence that these activities can lead to more use of expensive new drugs over equally effective cheaper options. Given these concerns there have been efforts by some hospitalls and practices to restrict these forms of marketing.
We asked physicians in group practices delivering primary care about how often pharmaceutical reps visit their practice and whether they have a free sample closet.
Dr. Brashear[/caption]
Allison Brashear, M.D., M.B.A.
Dean, UC Davis School of Medicine
MedicalResearch.com: What is the background for this study? Why is the demand for neurology services and neurologists increasing?
Response: The American Academy of Neurology estimates that by 2025 the number of neurologists in practice will increase to 18,060 but some 3,400 more will be needed to meet the demand for their services. The 58% increase in the number of residency positions in the National Resident Matching Program since 2008 also reflects the growing demand. The higher prevalence of neurologic conditions, aging U.S. population and more patients having access to the health care coverage are the major driving forces. (Note: source of NRMP neurology trend data comes from a physician/resident forum posted May 2019 https://forums.studentdoctor.net/threads/growth-trends-in-neurology-residency-positions.1375918/)
MedicalResearch.com: Why is neurology included among the less desirable fields of medicine (similar to nephrology, infectious disease, endocrinology etc.) for medical students and residents to pursue? Why is burnout and dissatisfaction so high?
Response: According to the American Academy of Neurology, a minority of medical students choose to train in neurology each year, with approximately 3.1% matching into a neurology residency in 2018. The newer generations of neurologists value lifestyle and time off work more than their predecessors.
According to a recent American Medical Association survey, neurology tied with critical care as the medical specialty with the highest stress levels and burnout. Too many administrative tasks, too many hours at work, increased computerization of practice and insufficient compensation were among the top causes of burnout.
Dr. Sabik[/caption]
Dr. Lindsay Sabik, Ph.D.
Associate Professor
Graduate School of Public Health
Department of Health Policy and Management
University of Pittsburgh
MedicalResearch.com: What is the background for this study?
Response: In 2006, Massachusetts passed a health insurance reform law with the aim of providing health care access to nearly all of its residents. My colleagues and I pulled data from the Massachusetts Cancer Registry on all colorectal and breast cancer cases in people ages 50- to 64-years-old from 2001 through 2013.
We selected those two cancers for our study because both are common, have routine screening guidelines and have high survival rates when caught early. The age range captured people covered by the recommended screening guidelines but not old enough to qualify for Medicare. We also pulled similar data from several other states for comparison.
Dr. Piper[/caption]
Brian Piper PhD
Department of Medical Education
Geisinger Commonwealth School of Medicine
Center for Pharmacy Innovation & Outcomes
Geisinger Precision Health Center
MedicalResearch.com: What is the background for this study?
Response: Disclosure of funding sources is standard practice for journal articles and clinical practice guidelines in order to alert readers to potential conflicts of interest (CoI). However, CoI disclosure is uncommon for textbooks. A new edition of Goodman and Gilman’s Pharmacological Basis of Therapeutics (GG-PBT) was recently published. This is affectionately known as “the blue bible of pharmacology” because it is widely used in the training of doctors, pharmacists, dentists, scientists, and nurses. This provided an opportunity to extend upon past research2,3 and determine whether the authors and editors had undisclosed CoIs.
Dr. Douglas[/caption]
Raymond S Douglas MD PhD
Professor of Surgery, Division of Ophthalmology
Director of the Orbital and Thyroid Eye Disease Program
Cedars Sinai Medical Center
MedicalResearch.com: What is the background for this study?
Response: Thyroid eye disease (TED) is a debilitating disease that affects all aspects of a patients life. It is often associated with Graves' disease and thyroid abnormalities. TED causes profound bulging of the eyes impairing vision, causing eye pain and facial disfigurement.
Dr. Schlaff[/caption]
William D Schlaff MD
Chair, Department of Obstetrics & Gynecology
Jefferson University
MedicalResearch.com: What is the background for this study?
Response: Symptomatic uterine fibroids are the most common indication for hysterectomy in the US. Heavy bleeding is the most common and troublesome symptom. The primary treatment for this problem is surgery—either hysterectomy or (less commonly) myomectomy. Medical treatment which reduces the bleeding related to fibroids without surgery is a valuable treatment for many women. Existing medications include, most commonly GnRH agonists. These are injectable medications that are given every 1 or 3 months (depending on the formulation) and have been shown to reduce bleeding related to fibroids. They work by initially stimulating the ovaries to increase estrogen levels for 10-14 days before suppressing estrogen and thereby reducing bleeding. Even though the medication is given every 1 or 3 months, the effect of the medication can last quite a bit longer; in cases of adverse response, the medication cannot be immediately stopped. The medication reported in this trial, Elagolix, is a GnRH antagonist given by mouth twice daily and resulting in suppression of estrogen secretion within a matter of hours. The effect of this medication wears off much more rapidly than the depot formulations described and can be stopped in the uncommon cases of adverse side effects.
Dr. Marcotte[/caption]
Leah Marcotte, MD
Clinical Assistant Professor, Medicine
University of Washington
Dr. Liao[/caption]
Joshua M. Liao, MD, MSc, FACP
Assistant Professor, Department of Medicine
Director, UW Medicine Value and Systems Science Lab
Medical Director of Payment Strategy, UW Medicine
University of Washington
Dr. Yano[/caption]
Yuichiro Yano MD
Assistant Professor in Family Medicine and Community Health
Duke University
MedicalResearch.com: What is the background for this study?
Response: The blood pressure (BP) guideline in the US recommend using an “average” of multiple BP measurements over time for screening for and management of high BP in young adults. While it is well known that BP varies across visits, that “variability” (i.e., visit-to-visit blood pressure variability) is dismissed as a random fluctuation in the clinical setting.
Little is known regarding the clinical relevance of visit-to-visit blood pressure variability over time in young adults.
MedicalResearch.com: What is the background for this study?
Response: A prior pilot study published in JAMA in May 2019 demonstrated the systemic absorption of 4 sunscreen active ingredients; additional studies are needed to determine the systemic absorption of additional active ingredients, and how quickly absorption occurs. This study assessed the systemic absorption of the 6 active ingredients (avobenzone, oxybenzone, octocrylene, homosalate, octisalate and octinoxate) in 4 sunscreen products under single and maximal-use conditions.
Dr. Campbell[/caption]
Dr. Dianne Campbell, MBBS, FRACP, PhD
VP, Global Medical Affairs
DBV Technologies
MedicalResearch.com: What is the background for this study?
Response: The PEOPLE study is an open-label extension of the Phase III PEPITES trial designed to evaluate the long-term safety, tolerability and efficacy of Viaskin Peanut 250 μg (NCT03013517) in peanut-allergic children ages 4 to 11 years . Participants who completed the 12-month study period of PEPITES were eligible to enroll in PEOPLE. Patients who were randomized to active treatment in PEPITES are eligible to receive up to four additional years of treatment, and those previously receiving placebo are eligible to receive up to five years of treatment.
The current study reports on the 3 year outcomes of children who were initially randomized to receive active treatment in the PEPITES study and completed an additional 2 years of treatment during the PEOPLE study. The study evaluated the eliciting dose (ED) after three years (Month 36) of active treatment using a double-blind, placebo-controlled food challenge (DBPCFC). The starting dose of each challenge was 1 mg of peanut protein and escalated to the highest dose of 2,000 mg peanut protein; possibly repeated once to reach a maximum total cumulative dose of 5,444 mg peanut protein. All participants who reached an ED ≥ 1,000 mg at Month 36 were eligible to continue the study for two additional months without treatment while maintaining a peanut-free diet. A further double-blind placebo-controlled food challenge to determine ED was administered at the end of this period (Month 38).
Additional analyses include exploratory assessments of safety parameters, immune biomarkers such as immunoglobulin G4 (IgG4) and immunoglobulin E (IgE).
Dr. Shan[/caption]
Zhilei Shan PhD
Postdoctoral fellow on Nutritional Epidemiology
Harvard T.H. Chan School of Public Health
MedicalResearch.com: What is the background for this study?
Response: Long-standing controversies have focused on the health consequences of dietary fat and carbohydrate. Previous evidence has shown that different types of carbohydrates and fats have varying effects on disease risk and health. For example, carbohydrates from refined grains and added sugars may contribute to insulin resistance and other metabolic problems while carbohydrates from whole grains and whole fruits appear to be beneficial. Likewise, replacing saturated fat with unsaturated fat was associated with lower risk of heart disease and mortality.
Therefore, it is crucial to incorporate quality and types of carbohydrate and fat when investigating the associations of low-fat and low-carbohydrate diets with mortality.
The most obvious take away is that correcting the magnesium levels can help patients to normalize calcium levels due to the synergy between the two....
Dr. Jonathan Silverberg[/caption]
Dr. Jonathan L. Silverberg MD PhD MPH
Director of Clinical Research and Contact Dermatitis
Associate Professor of Dermatology
George Washington University School of Medicine and Health Sciences
Washington, DC
MedicalResearch.com: What is the background for this study?
Response: We previously found that children from single parent families, and unsafe or unsupportive neighborhoods are more likely to have atopic dermatitis. Parents in these settings may experience greater psychosocial distress and higher rates of depression in the post-partum period and beyond.
As such, we sought to understand the relationship of maternal depression with atopic dermatitis in their children.
Dr. Winterdahl[/caption]
Michael Winterdahl PhD
Associate Professor in Neuroimaging,
Department of Nuclear Medicine and PET Center
Aarhus University, Denmark
MedicalResearch.com: What is the background for this study?
Response: Opioids and dopamine mediate the rewarding effects of drugs. We aimed to determine whether the intake of palatable food could lead to changes in the brain similar to those triggered by addictive substances, so we studied the effects of repeated intermittent access to sugar on opioid and dopamine receptors in porcine brain using neuroimaging.
Dr. DeFilippis[/caption]
Ersilia DeFilippis, MD
Second-year cardiology fellow
Columbia University Irving Medical Center and
NewYork-Presbyterian
MedicalResearch.com: What is the background for this study?
Response: Marijuana use has been increasing significantly and is the most commonly illicit drug used in the United States. In recent years, more states have been legalizing its use for both recreational and medicinal purposes. We have all seen news reports regarding the rise of vaping-related health hazards. Yet, data are limited regarding the cardiovascular effects of marijuana which is what drove us to explore this topic.
Prof. Andrea On Yan LUK[/caption]
Prof. Andrea On Yan LUK (陸安欣)
Associate Professor, Department of Medicine & Therapeutics
Faculty of Medicine, The Chinese University of Hong Kong
Specialist in Endocrinology, Diabetes and Metabolism
Honorary Associate Consultant, Hospital Authority
MedicalResearch.com: What is the background for this study?
Response: The overall mortality in people with diabetes has declined in many developed countries but little is known about the mortality trend in Asia. In this study, we examined the trend in mortality rates using a territory-wide database of 770,000 people with diabetes in Hong Kong.
Dr. Engzell[/caption]
Per Engzell PhD
Postdoctoral Prize Research Fellow
Nuffield College, University of Oxford
Annelise Madison[/caption]
Annelise Madison
Lead author of the study
Graduate Student in Clinical Psychology
Ohio State
MedicalResearch.com: What is the background for this study?
Response: Recently, there have been some reports of cognitive problems among those using proton pump inhibitors (PPIs). Some breast cancer survivors use PPIs during and after treatment to manage gastrointestinal side effects of cancer treatment or to prevent damage to the gut lining.
We were interested in whether PPI use among breast cancer survivors related to cognitive problems. We conducted secondary analyses on data from three studies with breast cancer survivors. We found that breast cancer survivors taking PPIs reported cognitive problems that were between 20-29% worse than those reported by non-users.
Dr. Graboyes[/caption]
Evan M. Graboyes, MD
Surveillance and Health Services Research
American Cancer Society, Atlanta, Georgia
Department of Otolaryngology–Head & Neck Surgery
Medical University of South Carolina, Charleston
MedicalResearch.com: What is the background for this study?
Response: Prior studies have shown that Medication Expansions under the Patient Protection and Affordable Care Act (ACA) are associated with a decrease in uninsured individuals and increases in the percentage of nonelderly patients diagnosed with localized (stage I-II) cancer, primarily for cancers for which effective screening tests exist.
Because no screening test exists for head and neck squamous cell carcinoma (HNSCC), access to care for physical examination and tissue-based biopsy- and thus health insurance coverage- are critical for the timely recognition of symptoms, early disease stage at diagnosis, and treatment initiation.
However, the downstream association of changes in health insurance coverage following Medicaid expansion under the ACA with stage at diagnosis and time to treatment initiation, key metrics for access to care for HNSCC, remain unknown.
Dr. Maldonado Lopez[/caption]
Rafael Maldonado Lopez MD PhD
Full professor
Departament de Ciències Experimentals i de la Salut
Universitat Pompeu Fabra
Barcelona
MedicalResearch.com: What is the background for this study?
Response: Endometriosis is a common, chronic and painful disease caused when the endometrium grows outside of the uterine cavity. These growths mainly affect organs in the pelvis causing pain and infertility, symptoms that are often accompanied with anxiety, depression, loss of working ability, and a substantial impact on quality of life. Current treatments include hormonal therapy and surgery, but the effectiveness of these treatments is rather limited, often have important unwanted side effects, and patients usually rely on self-management strategies. Therefore, there is an urgent need for researching new possible therapeutic approaches.
Dr. Paul Young[/caption]
Dr. Paul Young MBChB, BSc (Hons), FCICM
Medical Director of the Wakefield Hospital ICU
Head of the Intensive Care Research Unit
Wellington Hospital
MedicalResearch.com: What is the background for this study?
Response: Proton pump inhibitors (PPIs) are among the most widely prescribed drugs in the intensive care unit (ICU) in the world. Many, if not most, prescriptions of PPIs in the ICU are for stress ulcer prophylaxis. Although PPIs are used most widely for this indication, histamine-2 receptor blockers (H2RBs) are used in preference to PPIs in some ICUs. This practice variation, which appears to be largely dependent on clinician preference rather than based on patient-specific factors, has continued for decades. The PPIs vs. H2RBs for Ulcer Prophylaxis Therapy in the Intensive Care Unit (PEPTIC) trial results raise the possibility that PPIs, the most commonly used medicines for stress ulcer prophylaxis, may be responsible for a clinically important increase in the risk of death that, in global health terms could equate to many tens of 1000s of deaths per year.
Dr. Danziger[/caption]
John Danziger, MD
Harvard Medical Faculty Physicians, Nephrology
Beth Israel Deaconess Medical Center
MedicalResearch.com: What is the background for this study?
Response: Racial health disparities have long been described, extending even into the highest levels of medical care, namely the Intensive Care Unit (ICU).
Accordingly, we wanted to know whether improvements in ICU care seen over the last decade are equally observed in minority and non-minority serving hospitals.
Dr. Herrera-Escobar[/caption]
Juan P. Herrera-Escobar, MD, MPH
Research Director, Long-term Outcomes in Trauma
Center for Surgery and Public Health, Brigham and Women's Hospital
Instructor in Surgery, Harvard Medical School
MedicalResearch.com: What is the background for this study?
Response: Firearm injuries are a pressing public health problem in the United States. Until now, most of the research on this problematic has focused on mortality, which of course is critical, but is only one piece of the story. For every person who dies from a firearm injury, three survive every year. As trauma systems continue to improve and save more lives every year, our attention should start shifting to the impact that firearm injuries have on survivors.
Dr. Howell[/caption]
Elizabeth A. Howell, MD, MPP
Director of The Blavatnik Family Women’s Health Research Institute
Mount Sinai Health System Vice Chair for Research
Professor in the Department of Obstetrics, Gynecology, and Reproductive Science
Associate Dean for Academic Development
Professor Department of Population Health Science and Policy
Icahn Mount Sinai, New York
MedicalResearch.com: What is the background for this study?
Response: Previous research has demonstrated racial and ethnic disparities in severe maternal morbidity rates in hospitals and that between-hospital differences -- i.e., Black and Latina mothers receiving care at hospitals with worse outcomes -- explain a sizable portion of these disparities. However, less attention has been paid to within-hospital disparities -- whether Black and Latina mothers have worse outcomes than White mothers who deliver in the SAME hospital.
In this paper, we set out to measure within-hospital racial and ethnic disparities and to evaluate the potential contribution of insurance type to these disparities.
Our study question was based on the observation that women with Medicaid can follow different care pathways than women with private insurance. Pregnant women insured by Medicaid are often seen by resident physicians with attending coverage that may differ from attending physicians caring for commercially insured women. In addition, Medicaid reimbursement for delivery hospitalization is far less than that for commercially insured.